Serial change in echocardiographic parameters and cardiac failure in end-stage renal disease

Robert N. Foley, Patrick S. Parfrey, Gloria M. Kent, John D. Harnett, David C. Murray, Paul E. Barre

Research output: Contribution to journalArticlepeer-review

224 Scopus citations


Echocardiographic abnormalities are the rule in patients starting dialysis therapy and are associated with the development of cardiac failure and death. It is unknown, however, whether regression of these abnormalities is associated with an improvement in prognosis. As part of a prospective cohort study with mean follow-up of 41 mo, 227 patients had echocardiography at inception and after 1 yr of dialysis therapy. Improvements in left ventricular (LV) mass index, volume index, and fractional shortening were seen in 48, 48, and 46%, respectively. Ninety patients had developed cardiac failure by 1 yr of dialysis therapy. Twenty-six percent of the remaining 137 patients subsequently developed new-onset cardiac failure. The mean changes in LV mass index were 17 g/m2 in those who subsequently developed cardiac failure compared with 0 g/m2 among those who did not (P = 0.05). The corresponding values were -8 versus 0% for fractional shortening (P < 0.0001). The associations between serial change in both LV mass index and fractional shortening and subsequent cardiac failure persisted after adjusting for baseline age, diabetes, ischemic heart disease, and the corresponding baseline echocardiographic parameter. Regression of LV abnormalities is associated with an improved cardiac outcome in dialysis patients. Serial echocardiography adds prognostic information to one performed at baseline.

Original languageEnglish (US)
Pages (from-to)912-916
Number of pages5
JournalJournal of the American Society of Nephrology
Issue number5
StatePublished - May 2000


Dive into the research topics of 'Serial change in echocardiographic parameters and cardiac failure in end-stage renal disease'. Together they form a unique fingerprint.

Cite this